Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Food on Tofacitinib MR Pharmacokinetics
NCT02487433Phase 1Completed
- Sponsor
- Pfizer
- Start
- Jun 2015
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tofacitinib oral solution in ulcerative colitis (UC) (2 arms), sponsored by Pfizer. Primary endpoints: Area Under the Curve from Time Zero to Infinity, Area Under the Curve from Time Zero to Last Quantifiable Concentration and 1 more. Started Jun 2015; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02487433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02487433.